ClinConsent

What ClinConsent does

ClinConsent is a private, India-based SaaS company founded in 2017 and headquartered in Mysore, with a headcount range of 11-50 employees. According to its firmographic profile, the company positions itself as an eConsent tool intended to transform the informed consent process, implying a software platform supporting clinical trial or healthcare consent workflows — a functional area regulated under frameworks such as 21 CFR Part 11, ICH-GCP, and HIPAA, where electronic signature, audit trail, and IRB-aligned documentation are standard requirements.

The company's go-to-market, pricing model, customer segments, and revenue mechanics are not documented in the available sources. No product architecture details, integration footprint, named customer logos, or partnership ecosystem are reported. Co-founder and CEO Anil Kumar Mallikarjuna is the only leadership entry on record.

Critically, the company's primary web domain (ClinConsent.com) is listed for sale on HugeDomains for $1,995, with no active company website, product collateral, or operational signals recoverable from public sources. The only adjacent third-party signal — a market sizing reference for the global eConsent in Healthcare market (USD 534.3M in 2024, projected USD 1,211.8M by 2034 at 9.3% CAGR) — does not reference ClinConsent as a participant. Taken together, the evidence points to a micro-cap entity that may be inactive, wind-down, or pre-commercial, with material data gaps across every operating dimension.

Name

ClinConsent

Website

https://clinconsent.com

Company type

Private

Founded year

2017

Headcount range

1–10 employees

Short description

ClinConsent is an India-based SaaS company founded in 2017 that positioned itself as an electronic informed-consent platform for clinical research workflows; its primary web domain is currently listed for sale and no active operating signals are documented.

Ownership category

akta.pro rank

Product category

Clinical Trial eConsent Software

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN)

Keywords

• EConsent platform
• Clinical trial consent
• Informed consent software
• Clinical research technology
• Healthcare consent management

Headquarters

HQ city

Mysore

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

ClinConsent provides a SaaS eConsent tool designed to transform the informed consent process for clinical and healthcare use cases. The offering addresses the digitization of paper-based consent workflows in clinical research settings, operating in the eConsent-in-healthcare market segment.

Differentiator

Problem solved

Functional benefit

Products and services

• ClinConsent eConsent Platform

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves2 records

Broad incumbents

• IQVIA: IQVIA offers an eConsent solution integrated into its broader clinical development and technology services portfolio. As a top global CRO and clinical technology incumbent, it competes for the same sponsor budgets and represents a structural threat to small eConsent vendors.
• Veeva Systems: Veeva provides Veeva Vault eConsent as part of its broader clinical trial and life sciences cloud suite. It is the dominant enterprise incumbent in regulated life sciences workflows, competing head-on with a small standalone eConsent vendor.
• Medidata (Dassault Systèmes): Medidata's Rave platform includes eConsent as part of its industry-leading EDC, eCOA, and clinical trial technology stack. It is a directly comparable enterprise platform addressing the same informed-consent workflow as ClinConsent.
• Evinova (AstraZeneca): Evinova is a digital health and clinical trial technology business spun out of AstraZeneca offering eConsent and remote trial solutions. It is a well-capitalized, pharma-backed incumbent that competes in the same enterprise eConsent market.

Direct peers

• Signant Health: Signant Health (formed from CRF Health and Merge eClinical) is a dedicated eCOA/eConsent and clinical technology provider serving global sponsors and CROs. It is one of the closest direct competitors to a focused eConsent SaaS vendor.
• Y-Prime: Y-Prime is a clinical trial technology provider with an eCOA and eConsent offering focused on improving trial operational efficiency. It is a comparable mid-size peer competing for similar sponsor and CRO relationships.
• Clinical Ink: Clinical Ink offers an eCOA/eConsent suite (SureSource Engage) used by global sponsors in clinical research. It is a focused direct competitor with comparable product depth in the eConsent workflow.

Emerging players

• THREAD: THREAD provides a decentralized clinical trial platform including eConsent, telehealth, and eCOA capabilities. It is an emerging peer competing for similar decentralized and hybrid trial sponsors.
• ObvioHealth: ObvioHealth is a digital CRO offering an integrated eConsent-enabled decentralized trial platform. It overlaps with ClinConsent at the intersection of eConsent tooling and clinical trial delivery.
• Castor: Castor provides an EDC platform with eConsent capabilities aimed at academic and commercial trials. It is an emerging competitor targeting many of the same mid-tier and academic trial customers that a small eConsent SaaS would pursue.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClinConsent